BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu J, Hazen RJ, Joyce C, Delpino A, Kirkham HS, Strickland CD, Markes-wilson S, Kim T, Kang M, Rubin RA, Stein LL. Local specialty pharmacy and specialty clinic collaboration assists access to hepatitis C direct-acting antivirals. Journal of the American Pharmacists Association 2018;58:89-93.e2. [DOI: 10.1016/j.japh.2017.10.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Gunn J, Higgs P. Pharmacies dispensing opioid substitution therapy also play a role in hepatitis C virus elimination. Journal of the American Pharmacists Association 2018;58:245. [DOI: 10.1016/j.japh.2018.01.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Zuckerman A, Carver A, Chastain CA. Building a Hepatitis C Clinical Program: Strategies to Optimize Outcomes. Curr Treat Options Infect Dis. 2018;10:431-446. [PMID: 30524209 DOI: 10.1007/s40506-018-0177-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
3 Hecht B, Frye C, Holland W, Holland CR, Rhodes LA, Marciniak MW. Analysis of prior authorization success and timeliness at a community-based specialty care pharmacy. J Am Pharm Assoc (2003) 2021;61:S173-7. [PMID: 33618986 DOI: 10.1016/j.japh.2021.01.001] [Reference Citation Analysis]
4 Biondi MJ, Feld JJ. Hepatitis C models of care: approaches to elimination. CanLivJ 2020;3:165-76. [DOI: 10.3138/canlivj-2019-0002] [Reference Citation Analysis]
5 Boodram B, Kaufmann M, Aronsohn A, Hamlish T, Peregrine Antalis E, Kim K, Wolf J, Rodriguez I, Millman AJ, Johnson D. Case Management and Capacity Building to Enhance Hepatitis C Treatment Uptake at Community Health Centers in a Large Urban Setting. Fam Community Health. 2020;43:150-160. [PMID: 32079971 DOI: 10.1097/fch.0000000000000253] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kapadia SN, Marks KM. Hepatitis C Management Simplification From Test to Cure: A Framework for Primary Care Providers. Clin Ther 2018;40:1234-45. [PMID: 29983266 DOI: 10.1016/j.clinthera.2018.05.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
7 Fanizza FA, Loucks J, Berni A, Shah M, Grauer D, Daniel S. Patient Access to Hepatitis C Treatment After Incorporation of Pharmacists in a Hepatology Clinic. Hosp Pharm. [DOI: 10.1177/00185787211037540] [Reference Citation Analysis]
8 Sabourin AA, Fisher-Grant KK, Saulles AR, Mohammad RA. Evaluation of a specialty hepatitis C virus telephone pharmacy service. Am J Health Syst Pharm 2021;78:S38-45. [PMID: 33684928 DOI: 10.1093/ajhp/zxaa423] [Reference Citation Analysis]
9 Spradling PR, Zhong Y, Moorman AC, Rupp LB, Lu M, Gordon SC, Teshale EH, Schmidt MA, Daida YG, Boscarino JA; Chronic Hepatitis Cohort Study (CHeCS) Investigators. Psychosocial Obstacles to Hepatitis C Treatment Initiation Among Patients in Care: A Hitch in the Cascade of Cure. Hepatol Commun 2021;5:400-11. [PMID: 33681675 DOI: 10.1002/hep4.1632] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]